Article Versions Notes

Clémenceau B, Guillaume T, Coste-Burel M, Peterlin P, Garnier A, Le Bourgeois A, Jullien M, Ollier J, Grain A, Béné MC, et al. SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine. Vaccines. 2022; 10(3):448. https://doi.org/10.3390/vaccines10030448

Clémenceau, Béatrice, Thierry Guillaume, Marianne Coste-Burel, Pierre Peterlin, Alice Garnier, Amandine Le Bourgeois, Maxime Jullien, Jocelyn Ollier, Audrey Grain, Marie C. Béné, and et al. 2022. "SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine" Vaccines 10, no. 3: 448. https://doi.org/10.3390/vaccines10030448

Clémenceau, B., Guillaume, T., Coste-Burel, M., Peterlin, P., Garnier, A., Le Bourgeois, A., Jullien, M., Ollier, J., Grain, A., Béné, M. C., Vié, H., & Chevallier, P. (2022). SARS-CoV-2 T-Cell Responses in Allogeneic Hematopoietic Stem Cell Recipients following Two Doses of BNT162b2 mRNA Vaccine. Vaccines, 10(3), 448. https://doi.org/10.3390/vaccines10030448